エトグリフロジンによるエウグライセミック糖尿病ケトアシドーシス 炎後の糖尿病:症例報告
Jiang-Tao Chai1, Xin-Hui Li1, Zhao-Shun Jiang2
1Department of Endocrinology, 960th Hospital of PLA, Jinan 250014, Shandong Province, China.
World journal of clinical cases
|August 29, 2025
まとめ
ナトリウム・グルコース・コトランスポーター-2 (SGLT-2) 阻害剤は,パンクレアチス後の糖尿病患者において,ユーグリセミック糖尿病ケトアシドーシス (euDKA) を引き起こす可能性があります. インスリン治療は,この深刻な合併症を予防するために推奨されます.
科学分野:
- 内分泌学
- 代謝障害
- 薬理学について
背景:
- ナトリウム・グルコース・コトランスポーター-2 (SGLT-2) 阻害剤は糖尿病の管理に使用され,心血管および腎臓のアウトカムを改善します.
- これらの薬剤は,インスリン独立経路を通じて,ユーグリセミック糖尿病性ケトアシドーシス (euDKA) を誘発する可能性があります.
- ベータ細胞機能の障害による臓炎後の糖尿病 (PPDM) のSGLT-2阻害剤のリスクは十分に定義されていません.
研究 の 目的:
- SGLT-2 阻害剤で治療されたPPDM患者におけるeuDKAの潜在的なリスクを強調する.
- この患者集団にこれらの薬を処方する際の注意の必要性を強調するためです.
主な方法:
- エトグリフロジン投与開始後にエウダカを発症した 29歳の男性に関する症例報告
- 入院時の検査結果:血中ケトンの値4. 5mmol/L,pHの値7. 1およびグルコースの値10. 78mmol/L
- SGLT - 2 阻害剤の中止,インスリンポンプ療法,積極的な水分補給,栄養補助を含む管理戦略を説明した.
主要な成果:
- エトグリフロジン投与開始から1週間後,患者さんはエウダカを発症しました.
- 薬物中断,インスリン療法,水分補給,栄養による治療により,24時間以内にケトーシスとアシドーシスが解消された.
- このケースは,PPDMにおけるSGLT-2阻害剤使用に関連した潜在的な有害事象を示しています.
結論:
- SGLT-2 阻害剤は,PPDMの患者では慎重に使用する必要があります.
- インスリン治療は,PPDMにおける糖尿病の管理において,euDKAのリスクを軽減するための好ましい治療方法である.
- この特定の糖尿病患者集団におけるリスクと利益を完全に解明するには,さらなる研究が必要かもしれません.
関連する概念動画
Acute Pancreatitis II: Clinical Manifestations and Management
175
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
175
Diabetes: Symptoms, Diagnosis, and Complications
685
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
685
Hypoglycemia and Glucagon
334
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
334
Dipeptidyl Peptidase 4 Inhibitors
252
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
252
Acute Pancreatitis I: Introduction
476
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
476
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K


